Unique Global Commercialization Platform for Proven Innovators

Share This Article

World population is projected to reach 9.8 billion in 2050 and 11.2 billion in 2100. As the world population continues to grow, the need for more and higher quality food is rapidly in- creasing. In order to obtain higher yields from one unit area of crop production, the need for higher-quality, more effective, and safer pesticides, biostimulants and plant nutrition prod- ucts increases. Ensuring the safety of these products for hu- mans and the environment is a major concern.
In these areas, R&D activities by universities and other research institutions, multinational R&D-based companies, and startup companies are progressing rapidly, offering many innovative products to farmers for higher-quality and more abundant crop production. It is estimated that studies on these issues will continue in the coming years, and innovative products will become more widespread.

A UNIQUE BUSINESS MODEL

We provide a unique commercialization platform for sin- cere innovators to commercialize integrated sustainable soil- to-shelf plant health solutions for farmers globally. Millions of dollars are going into R&D of BioAg products globally, however

there are a few companies that can and will successfully scale. Most R&D companies have to invest and perfect one technol- ogy platform or the other as its very intensive and demanding for cash. After investing on R&D, some of these companies find out how challenging it is to “cross the chasm” and gain market adoption. They run out of cash or must invest even more (meaning dilute further) to meet commercialization needs. In most cases, they remain local due to global expansion cost and regulatory barriers.

The founders of Global BioAg Innovations (GBI), global agriculture commercialization experts and business builders, conceptualized GBI to provide commercialization partnership opportunities to outstanding innovators. This is the first of its kind. A global commercialization platform for our own inno- vations and other innovators who have spent millions in de- veloping outstanding BioAg technology but have limited or no access to the global market. By formulating uniquely tailored and exclusive GBI formulations though our own innovations and also through estab- lished innovators with an alternate revenue stream for them.

Best of the Best Innovations of Varied Technologies Under One Umbrella
Our focused model is based on true partnerships at each level of formulation/production, business development and prod- uct distribution for targeting a tangible ROI for our farmers and safe food for consumers. With the extensive knowledge and ever fresh market intelligence of founders, new formula- tions and innovations that are being developed, these innovators are bringing path breaking products and innovations.

With this unique model that Global BioAg Innovations has, we develop, register and distribute innovative, safe, differentiat- ed and effective biopesticides, biostimulants and biological origin of plant nutrition products we have developed together with our Innovation Partners worldwide.

FOUNDATION BLOCKS AND VALUES OF GBI BUSINESS MODEL

 


PROVEN, UNIQUE, WELL-DIFFERENTIATED, SAFE, EFFICACIOUS

Our product range is developed in a way that is tailored to meet unique needs of plants for all critical stages of crop man- agement. This ensures improved crop productivity and profit- ability for farmers which contributes to food safety and food se- curity for consumers. In order to safeguard farmers’ interests, GBI has experts from all agricultural areas such as crop produc- tion, entomology and plant nutrition on its team to ensure that products offered are genuine and good not only for plants and soil, but also for the environment and whole food chain.
Our global and local experts, and our local Distribution Partners work together with our expansive portfolio. They are used very effectively in different countries, on different crops, and for different needs, in accordance with the purpose mentioned above.

 

Leave a Reply